Literature DB >> 11171064

Recognition sequences and structural elements contribute to shedding susceptibility of membrane proteins.

K Althoff1, J Müllberg, D Aasland, N Voltz, K Kallen, J Grötzinger, S Rose-John.   

Abstract

Although regulated ectodomain shedding affects a large panel of structurally and functionally unrelated proteins, little is known about the mechanisms controlling this process. Despite a lack of sequence similarities around cleavage sites, most proteins are shed in response to the stimulation of protein kinase C by phorbol esters. The signal-transducing receptor subunit gp130 is not a substrate of the regulated shedding machinery. We generated several chimaeric proteins of gp130 and the proteins tumour necrosis factor alpha (TNF-alpha), transforming growth factor alpha (TGF-alpha) and interleukin 6 receptor (IL-6R), which are known to be subject to shedding. By exchanging small peptide sequences of gp130 for cleavage-site peptides of TNF-alpha, TGF-alpha and IL-6R we showed that these short sequences conferred susceptibility to spontaneous and phorbol-ester-induced shedding of gp130. Importantly, these chimaeric gp130 proteins were functional, as shown by the phosphorylation of gp130 and the activation of signal transduction and activators of transcription 3 ('STAT3') on stimulation with cytokine. To investigate minimal requirements for shedding, truncated cleavage-site peptides of IL-6R were inserted into gp130. The resulting chimaeras were susceptible to shedding and showed the same cleavage pattern as observed in the chimaeras containing the complete IL-6R cleavage site. Surprisingly, we could also generate cleavable chimaeras by exchanging the juxtamembrane sequence of gp130 for the corresponding region of leukaemia inhibitory factor ('LIF') receptor, a protein that like gp130 is not subject to regulated or spontaneous shedding. Thus it seems that there is no minimal consensus shedding sequence. We speculate that structural changes allow the access of the protease to a membrane-proximal region, leading to shedding of the protein.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11171064      PMCID: PMC1221613          DOI: 10.1042/0264-6021:3530663

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  51 in total

1.  Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease.

Authors:  S Lammich; E Kojro; R Postina; S Gilbert; R Pfeiffer; M Jasionowski; C Haass; F Fahrenholz
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

2.  Structural requirements for inducible shedding of the p55 tumor necrosis factor receptor.

Authors:  C Brakebusch; E E Varfolomeev; M Batkin; D Wallach
Journal:  J Biol Chem       Date:  1994-12-23       Impact factor: 5.157

3.  Processing of tumour necrosis factor-alpha precursor by metalloproteinases.

Authors:  A J Gearing; P Beckett; M Christodoulou; M Churchill; J Clements; A H Davidson; A H Drummond; W A Galloway; R Gilbert; J L Gordon
Journal:  Nature       Date:  1994-08-18       Impact factor: 49.962

4.  Differential shedding of the two subunits of the interleukin-6 receptor.

Authors:  J Müllberg; E Dittrich; L Graeve; C Gerhartz; K Yasukawa; T Taga; T Kishimoto; P C Heinrich; S Rose-John
Journal:  FEBS Lett       Date:  1993-10-11       Impact factor: 4.124

5.  The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site.

Authors:  J Müllberg; W Oberthür; F Lottspeich; E Mehl; E Dittrich; L Graeve; P C Heinrich; S Rose-John
Journal:  J Immunol       Date:  1994-05-15       Impact factor: 5.422

6.  Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor.

Authors:  G M McGeehan; J D Becherer; R C Bast; C M Boyer; B Champion; K M Connolly; J G Conway; P Furdon; S Karp; S Kidao
Journal:  Nature       Date:  1994-08-18       Impact factor: 49.962

7.  Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing.

Authors:  K M Mohler; P R Sleath; J N Fitzner; D P Cerretti; M Alderson; S S Kerwar; D S Torrance; C Otten-Evans; T Greenstreet; K Weerawarna
Journal:  Nature       Date:  1994-07-21       Impact factor: 49.962

8.  A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes.

Authors:  P D Crowe; B N Walter; K M Mohler; C Otten-Evans; R A Black; C F Ware
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

9.  Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15.

Authors:  J G Giri; M Ahdieh; J Eisenman; K Shanebeck; K Grabstein; S Kumaki; A Namen; L S Park; D Cosman; D Anderson
Journal:  EMBO J       Date:  1994-06-15       Impact factor: 11.598

10.  Mutational analysis of the membrane-proximal cleavage site of L-selectin: relaxed sequence specificity surrounding the cleavage site.

Authors:  G I Migaki; J Kahn; T K Kishimoto
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

View more
  23 in total

1.  Synthetic Deletion of the Interleukin 23 Receptor (IL-23R) Stalk Region Led to Autonomous IL-23R Homodimerization and Activation.

Authors:  Thorben M Hummel; Theresa Ackfeld; Marco Schönberg; Gregor Ciupka; Falk Schulz; Anne Oberdoerster; Joachim Grötzinger; Jürgen Scheller; Doreen M Floss
Journal:  Mol Cell Biol       Date:  2017-08-11       Impact factor: 4.272

2.  Neuronal brain-derived neurotrophic factor is synthesized in excess, with levels regulated by sortilin-mediated trafficking and lysosomal degradation.

Authors:  Sarah Felice Evans; Krithi Irmady; Katya Ostrow; Taeho Kim; Anders Nykjaer; Paul Saftig; Carl Blobel; Barbara L Hempstead
Journal:  J Biol Chem       Date:  2011-07-05       Impact factor: 5.157

3.  Roles of the juxtamembrane and extracellular domains of angiotensin-converting enzyme in ectodomain shedding.

Authors:  S Pang; A J Chubb; S L Schwager; M R Ehlers; E D Sturrock; N M Hooper
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

4.  Non-canonical interleukin 23 receptor complex assembly: p40 protein recruits interleukin 12 receptor β1 via site II and induces p19/interleukin 23 receptor interaction via site III.

Authors:  Jutta Schröder; Jens M Moll; Paul Baran; Joachim Grötzinger; Jürgen Scheller; Doreen M Floss
Journal:  J Biol Chem       Date:  2014-11-04       Impact factor: 5.157

5.  Canine distemper virus and measles virus fusion glycoprotein trimers: partial membrane-proximal ectodomain cleavage enhances function.

Authors:  Veronika von Messling; Dragana Milosevic; Patricia Devaux; Roberto Cattaneo
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

6.  Ectodomain shedding of the glycoprotein GP of Ebola virus.

Authors:  Olga Dolnik; Valentina Volchkova; Wolfgang Garten; Caroline Carbonnelle; Stephan Becker; Jörg Kahnt; Ute Ströher; Hans-Dieter Klenk; Viktor Volchkov
Journal:  EMBO J       Date:  2004-04-22       Impact factor: 11.598

7.  Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10.

Authors:  Cristina I Caescu; Grace R Jeschke; Benjamin E Turk
Journal:  Biochem J       Date:  2009-10-23       Impact factor: 3.857

8.  Identification of canonical tyrosine-dependent and non-canonical tyrosine-independent STAT3 activation sites in the intracellular domain of the interleukin 23 receptor.

Authors:  Doreen M Floss; Simone Mrotzek; Tobias Klöcker; Jutta Schröder; Joachim Grötzinger; Stefan Rose-John; Jürgen Scheller
Journal:  J Biol Chem       Date:  2013-05-14       Impact factor: 5.157

Review 9.  Serum interleukin-6 levels in colorectal cancer patients--a summary of published results.

Authors:  Heike Knüpfer; Rainer Preiss
Journal:  Int J Colorectal Dis       Date:  2009-11-07       Impact factor: 2.571

10.  Minimal interleukin 6 (IL-6) receptor stalk composition for IL-6 receptor shedding and IL-6 classic signaling.

Authors:  Paul Baran; Rebecca Nitz; Joachim Grötzinger; Jürgen Scheller; Christoph Garbers
Journal:  J Biol Chem       Date:  2013-04-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.